PRECISION BIOSCIENCES INC Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
PRECISION BIOSCIENCES INC (DTIL) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $7.00 million as of 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2026-03-12
- 2025-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $7.00M.
- 2025-03-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $9.70M.
- 2024-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $12.70M.
- 2024-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $16.70M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2025-12-31 | $7.00M 10-K · filed 2026-03-12 |
| 2025-03-31 | $9.70M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $12.70M 10-K · filed 2025-03-26 |
| 2024-09-30 | $16.70M 10-Q · filed 2024-11-04 |
| 2024-06-30 | $15.00M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $13.60M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $16.70M 10-K · filed 2024-03-27 |
| 2023-09-30 | $20.20M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $25.50M 10-Q · filed 2023-08-04 |
| 2023-03-31 | $29.60M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $31.50M 10-K · filed 2023-03-09 |
| 2022-09-30 | $34.70M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $40.40M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $43.20M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $35.30M 10-K · filed 2022-03-15 |
| 2021-09-30 | $36.30M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $44.30M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $27.10M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $30.50M 10-K · filed 2021-03-18 |
| 2020-09-30 | $33.10M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $33.60M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $28.90M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $29.00M 10-K · filed 2020-03-10 |
| 2019-09-30 | $30.30M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $25.00M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $23.20M 10-Q · filed 2019-04-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |